AstraZeneca’s COVID-19 vaccine shows ‘encouraging’ immune response in older adults

The experimental COVID-19 vaccine being developed by AstraZeneca and Oxford University produces a strong immune response in older adults, data from early trials have shown.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.